A COMPARATIVE STUDY OF VIDANGADI LAUHA AND PATHYAA GHRITA (SHAMANA SNEHA) IN THE MANAGEMENT OF PANDU ROGA
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 34
- Locations
- 1
- Primary Endpoint
- BY OBSERVING CLINICAL IMPROVEMENT IN SIGN AND SYMPTOM OF PANDU ROGA AND LABORATERY INVESTIGATIONS BEFORE AND AFTER TREATMENT
Study Overview
Brief Summary
THIS STUDY IS A RANDOMISED, PARTICIPENT BLINDED, PRALLEL GROUP, ACTIVE CONTROLLED TRIAL TO COMPARE THE EFFICACY OF PATHYAA GHRITA IN DOSE OF 15 ml IN MORNING ANNAPRAKANKSHE KALE WITH VEHICAL OF USHNODAKA AND VIDANGADI LAUHA 4 TABLETS (250 mg EACH) BD WITH VEHICAL OF WATER FOR THE DURATION OF 1 MONTH AND 15 DAYS IN 17 PATIENTS OF PANDU ROGA ANDVIDANGADI LAUHA 4 TABLETS (250 mg EACH) BD WITH VEHICAL OF WATER FOR THE DURATION OF 1 MONTH AND 15 DAYS IN 17 PATIENTS OF PANDU ROGA WILL BE CONDUCTED IN INDIA
Study Design
- Study Type
- Interventional
- Allocation
- Coin toss, Lottery, toss of dice, shuffling cards etc
- Masking
- Participant Blinded
Eligibility Criteria
- Ages
- 16.00 Year(s) to 60.00 Year(s) (—)
- Sex
- All
Inclusion Criteria
- •THE PATIENTS WILL BE SELECTED ON THE BASIS OF SIGN AND SYMPTOM OF PANDU ROGA DISCRIBED IN AYURVED CLASSIC, PATIENTS HAVING Hb- 6gm% TO 10gm%.
Exclusion Criteria
- •CONGENITAL ANEMIA LIKE THALASSEMIA, SICKEL CELL ANEMIA, LEUKEMIA, APLASTIC ANEMIA, ANEMIA DUE TO BLEEDING PILES, MENORRHAGIA MAJOR DISEASE LIKE CARDIC DISEASE, D.M.
Outcomes
Primary Outcomes
BY OBSERVING CLINICAL IMPROVEMENT IN SIGN AND SYMPTOM OF PANDU ROGA AND LABORATERY INVESTIGATIONS BEFORE AND AFTER TREATMENT
Time Frame: 1 MONTH AND 15 DAYS
Secondary Outcomes
No secondary outcomes reported
